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Major features of transcription by human RNA poly-
merase II (Pol II) remain poorly defined due to a
lack of quantitative approaches for visualizing Pol II
progress at nucleotide resolution. We developed
a simple and powerful approach for performing
native elongating transcript sequencing (NET-seq)
in human cells that globally maps strand-specific
Pol II density at nucleotide resolution. NET-seq
exposes a mode of antisense transcription that orig-
inates downstream and converges on transcription
from the canonical promoter. Convergent transcrip-
tion is associated with a distinctive chromatin
configuration and is characteristic of lower-ex-
pressed genes. Integration of NET-seq with genomic
footprinting data reveals stereotypic Pol II pausing
coincident with transcription factor occupancy.
Finally, exons retained in mature transcripts display
Pol II pausing signatures that differ markedly from
skipped exons, indicating an intrinsic capacity for
Pol II to recognize exons with different processing
fates. Together, human NET-seq exposes the topog-
raphy and regulatory complexity of human gene
expression.INTRODUCTION
High-throughput sequencing analyses of transcription have
discovered new classes of RNAs and new levels of regulatory
complexity. Many of these results were obtained with two exper-
imental strategies to measure RNA polymerase density genome
wide. The first, RNA polymerase II (Pol II) ChIP-seq or ChIP-chip,
identifies DNA bound to RNA polymerase. The second set of ap-
proaches, global run-on sequencing (GRO-seq) and precision
nuclear run-on and sequencing (PRO-seq), restarts RNA poly-
merase in vitro with labeled nucleotides to purify and sequence
nascent RNA (Core et al., 2008; Kwak et al., 2013). GRO-seq andPol II ChIP detect strong transcriptional pauses 50 bp down-
stream of many transcription start sites, demonstrating that pro-
moter-proximal pausing is more prevalent than initially observed
(Core et al., 2008; Krumm et al., 1992; Kwak et al., 2013; Muse
et al., 2007; Rahl et al., 2010; Rougvie and Lis, 1988; Strobl and
Eick, 1992; Zeitlinger et al., 2007). Abundant unstable transcripts
upstream of and antisense to promoters revealed that divergent
transcription is a common feature of eukaryotic promoters (Core
et al., 2008; Neil et al., 2009; Preker et al., 2008; Seila et al.,
2008; Xu et al., 2009). Despite progress in understanding how
these transcripts are terminated and degraded (Almada et al.,
2013; Ntini et al., 2013; Preker et al., 2008; Schulz et al.,
2013), their roles remain unknown (Wu and Sharp, 2013). Finally,
recent studies confirm that splicing is largely co-transcriptional
and splicing outcome is kinetically tied to elongation rate (Bhatt
et al., 2012; Davis-Turak et al., 2015; Dujardin et al., 2014; Fong
et al., 2014; Ip et al., 2011; de la Mata et al., 2003; Roberts et al.,
1998; Shukla et al., 2011; Tilgner et al., 2012). However, it has
been impossible to determine whether such kinetic coupling in
human cells is mediated by pausing events genome wide, due
to the high resolution required to measure pausing on short hu-
man exons.
The strongly stereotyped locations of promoter-proximal
pauses and divergent antisense transcription can be exposed
by averaging Pol II density from many genes (metagene anal-
ysis) obtained at low resolution (Core et al., 2008; Neil et al.,
2009; Preker et al., 2008; Rahl et al., 2010; Seila et al., 2008;
Xu et al., 2009). Yet, the precise architecture of promoter-asso-
ciated transcriptional activity and of pausing outside of pro-
moter regions has been obscured by the resolution limitations
of current methodologies, preventing deeper insight into the
underlying regulatory mechanisms. Indeed, the interplay be-
tween chromatin structure, transcription factors, and the tran-
scription machinery is largely undefined. Pol II ChIP-seq is typi-
cally limited in its resolution to >200 bp resolution and lacks
strand specificity. GRO-seq is similarly limited to 50 bp reso-
lution, and although PRO-seq has higher resolution, both run-
on methods require transcription elongation complexes to
resume polymerization in vitro, a variable process sensitive to
the experimental conditions and the Pol II pausing state (Core
et al., 2008; Weber et al., 2014). Recently, we showed thatCell 161, 541–554, April 23, 2015 ª2015 Elsevier Inc. 541
Figure 1. A Robust and Simplified NET-Seq
Approach for Human Cells
(A) Schematic view of the key steps of the human
NET-seq approach. The transcription inhibitor,
a-amanitin, is introduced at cell lysis and is main-
tained through all purification steps. Engaged RNA
polymerase is purified through the isolation of
chromatin. The 30 end of the co-purified nascent
RNA (red) is ligated to a linker containing a mixed
random hexameric sequence (blue) that serves
as a molecular barcode. After cDNA synthesis,
contaminant species are removedby hybridization.
PCR amplification results in a DNA-sequencing li-
brary with the sequencing primer binding site
proximal to the random hexamer barcode. Finally,
the 30 ends of the sequenced nascent RNA are
aligned to the human genome, yielding RNA poly-
merase density at nucleotide resolution. Analysis
of the molecular barcode allows reads arising from
DNA library construction artifacts to be filtered out.
(B) Representative western blot analysis of cellular
fractions in HeLa S3 cells. Subcellular localization
markers were also probed (chromatin marker,
histone 2B; nucleoplasm marker, U1 snRNP70;
cytoplasm marker, GAPDH).
(C) Histograms of the size-normalized ratio of
subcellular RNA-seq reads that map to exons
versus introns for each gene.
(D) Number of uniquely aligned reads per Pol II
gene for two biological replicates from HeLa S3
cells (Pearson’s correlation, R = 0.97). 0.5 pseu-
docounts were added to genes with zero counts in
one of the replicates. The data set with higher
coverage was randomly downsampled to match
the total number of reads of the other data set.
See also Figure S1 and Table S1.the extraordinary stability of the RNA-DNA-RNA polymerase
ternary complex can be exploited to capture nascent RNA
(Churchman and Weissman, 2011). Native elongating transcript
sequencing (NET-seq) quantitatively purifies Pol II complexes
and sequences the 30 end of nascent RNA to reveal the
strand-specific position of Pol II with single-nucleotide resolu-
tion. NET-seq detects all transcriptionally engaged Pol II,
including productively transcribing Pol II, paused Pol II, and
Pol II recovering from pausing (Churchman and Weissman,
2011).
Here, we develop a NET-seq approach that quantitatively
defines the full spectrum of transcriptional activity in a
strand-specific manner and at nucleotide resolution in human
cells. We find that many promoters display antisense transcrip-
tion downstream of a promoter-proximal pause, resulting in
convergent sense and antisense transcriptional activities that
face one another in close proximity. Convergent transcription
is associated with a distinct chromatin conformation and is a
feature of lower-expressed genes, suggesting a possible regu-
latory role. NET-seq reveals that Pol II density profiles differ be-
tween retained exons, skipped exons, and introns in human
cells, indicating generalized kinetic coupling of transcription
and splicing. Human NET-seq is readily applicable to diverse
cell types and provides a general strategy to study transcrip-
tional complexity.542 Cell 161, 541–554, April 23, 2015 ª2015 Elsevier Inc.RESULTS
A Robust Human NET-Seq Methodology
The first step of NET-seq purifies nascent RNA through its tight
interaction with RNA polymerase. In yeast, this is achieved
through an epitope-tagged Pol II subunit that enables highly
quantitative purification and specific elution (Churchman and
Weissman, 2011). In adapting NET-seq to human cells, we bio-
chemically purify >99% of all engaged RNA polymerase in a
highly specific manner that can be applied to any mammalian
cell line or tissue without genetic modification (Figure 1A). This
method avoids using Pol II antisera, which could bias the popu-
lation of isolated Pol II complexes due to posttranslational mod-
ifications and epitope masking by heterogeneous Pol II binding
partners and structural conformations. Instead, human NET-
seq exploits the high stability of the RNA-DNA-RNA polymerase
ternary complex, even in the presence of high salt and urea (Cai
and Luse, 1987; Wuarin and Schibler, 1994), to purify engaged
RNA polymerase, along with its nascent RNA, through an asso-
ciation with chromatin after cellular fractionation into cytoplasm,
nucleoplasm, and chromatin (Bhatt et al., 2012; Pandya-Jones
and Black, 2009; Wuarin and Schibler, 1994). To prevent tran-
scriptional run-on during fractionation, lysate is kept at %4C,
and a-amanitin, a potent transcriptional inhibitor (Lindell et al.,
1970), is included in every step. Through optimization of current
fractionation approaches, we identified buffers and washing
conditions that cleanly purify >99% of elongating RNA polymer-
ase II (C-terminal domain [CTD] Ser2-P, Ser5-P, and the general
CTD hyper-phosphorylated form of Pol II) in the chromatin frac-
tion (see Experimental Procedures and Figures 1B and S1A).
Western blot analyses of Pol II isoforms and factors with well-
defined subcellular localizations verify the stringency of our frac-
tionation conditions (Figure 1B).
To confirm that our purification strategy specifically isolates
nascent RNA, we sequenced the RNA in each fraction. Unpro-
cessed RNA species, such as intron-containing Pol II transcripts
and spacer-containing Pol I transcripts (Figures 1C and S1B), are
heavily enriched in the chromatin fraction. Importantly, the large
majority of intron-containing RNAs observed in the nucleoplasm
persist to the cytoplasm, indicating that these RNAs are prod-
ucts of intron-retaining alternative splicing and not nascent tran-
scripts (Figure S1C). Together, these results demonstrate that
RNA polymerase and nascent RNA are quantitatively purified
through the isolation of chromatin.
The second step of the NET-seq approach requires
sequencing the 30 ends of the nascent RNA, which localizes
Pol II genome wide at nucleotide resolution (Churchman and
Weissman, 2011; Ferrari et al., 2013; Weber et al., 2014).
In large part, our yeast library construction protocol is used
(Churchman and Weissman, 2012), with two important changes
to account for the increased complexity of the human genome.
First, we addressed reverse transcription (RT) artifacts that arise
from the significant size of human nascent RNA. We found that
reverse transcription frequently initiates within the RNA if there
are stretches as short as six nucleotides of complementarity to
the RT primer (Figure S1D). When the 30 ends of the nascent
RNA are ligated to a linker pool, consisting of a random hexamer
at the 50 end followed by a common sequence, ligation efficiency
increases and mispriming events are dramatically reduced (Fig-
ure S1D). Furthermore, the hexamer serves as a molecular bar-
code for each molecule and enables the computational removal
of reads arising from residual mispriming events and PCR dupli-
cates. Second, we deplete abundant mature snRNAs, snoRNAs,
rRNA, and others through subtractive hybridization targeting
their 30 ends (Figure S1E, Table S1) to increase sequencing
coverage for nascent transcripts. Finally, library construction
steps are optimized to be highly efficient (>90%) and are contin-
ually monitored through quality controls to minimize bias.
Together, our optimized library construction protocol faithfully
converts the 30 ends of nascent human RNA to a DNA
sequencing library that allows the high-fidelity mapping of
strand-specific Pol II density.
To observe genome-wide transcriptional activity, a NET-seq
library was prepared from HeLa S3 cells and sequenced to
high coverage (768 million total reads, 360 million uniquely
aligned). Each sequencing read was aligned to the human
genome, and the genomic location of the 30 end of the nascent
RNA was recorded to map RNA polymerase density with nucle-
otide resolution. As expected, we recovered nascent RNA from
all three nuclear RNA polymerases (Pol I, Pol II, Pol III), as well as
mature chromatin-associated RNAs, such as snRNAs, and
splicing intermediates (Figures S1F and S1G). Here, we focused
our analysis on Pol-II-synthesized RNAs, but our results suggestthat the NET-seq approach is amenable to the study of other
RNA polymerases. Importantly, comparison of a biological repli-
cate library (175 million total reads, 83 million uniquely aligned)
shows strong agreement, indicating the robustness of the
approach (Pearson’s coefficient, 0.97, Figure 1D). To demon-
strate that NET-seq is easily adaptable to other cell lines, we
applied our approach to HEK293T cells and obtained data
from two replicates with similar reproducibility (replicate 1:
1.203 billion total reads, 555 million uniquely aligned; replicate
2: 358 million total reads, 135 million uniquely aligned; Fig-
ure S1H). From these analyses, we conclude that human
NET-seq is capable of quantitatively monitoring transcriptional
activity across the human genome and adaptation to new cell
lines is straightforward.
NET-Seq Reveals Transcriptional Activity at Nucleotide
Resolution Genome Wide
The resolution afforded by NET-seq and the sequencing
coverage obtained provide an in-depth view of genome-wide
transcriptional activity. The highest coverage is observed across
promoter-proximal regions, which we conservatively defined as
the region between the earliest annotated transcription start
site and +1 kb. Within this region, >50% of genes have coverage
of >1 read per kb per million uniquely aligned reads (RPKM) in
both HeLa S3 (Figures 2A and 2B) and HEK293T cells (Fig-
ure S2C). When coverage is calculated across entire genes,
the percentage decreases to <30% in both cell lines due to the
prevalence of promoter-proximal pausing (Figures 2A and 2B).
Indeed, most (89% in HeLa S3 cells and 94% in HEK293T cells)
expressed genes display promoter-proximal pausing defined by
a traveling ratio (coverage ratio between a narrow promoter-
proximal region and the gene body) ofR2, consistent with earlier
observations in mouse embryonic stem cells (Figures 2C and
S2D) (Rahl et al., 2010). Furthermore, we detect unstable RNA
production, antisense transcription upstreamofmany promoters
(89% in HeLa S3 cells and 82% in HEK293T cells), transcription
downstream of many polyadenylation sites (95% in HeLa S3
cells and 88% in HEK293T cells), and enhancer RNAs (Figures
S2A, S2B, S2E,and S2F).
NET-seq data describe transcriptional activity at many length
scales. At the single-gene level, strong signal is observed at pro-
moter regions and across introns (Figure 2D, top and middle).
Signal variation across the gene body suggests that transcription
elongation is discontinuous following release from promoter-
proximal regions and that pausing is a general feature during pro-
ductive Pol II transcription. Near transcription start sites (TSSs),
NET-seq detects sense and antisense transcription of divergent
promoters at single-nucleotide resolution, revealing that pro-
moter-proximal pausing does not occur at only one position;
instead, there are narrow regions of high Pol II density (Figure 2D,
bottom). Together, NET-seq data uncover key features of human
transcription activity, and the high resolution and the coverage of
the data provide deeper insight into these complexities.
Widespread Convergent Transcription in Promoter-
Proximal Regions
Several previous studies showed widespread divergent tran-
scription at eukaryotic promoters (Churchman and Weissman,Cell 161, 541–554, April 23, 2015 ª2015 Elsevier Inc. 543
Figure 2. NET-Seq Reports on Transcription Globally and Locally
(A) Schematic defining gene regions used in analysis of NET-seq data.
(B) Distributions of the percent of expressed Pol-II-transcribed protein-coding genes (n = 19,108), with a given Pol II coverage for different gene regions as defined
in Figure 2A.
(C) Distributions of the percent of well-expressed Pol II protein-coding genes (n = 8,912) with a given traveling ratio. Well-expressed Pol II genes are defined as
those genes with an RPKM of 1 or greater in a tight promoter-proximal region (30 bp to +300 bp of the TSS). Traveling ratio (TR) is defined as the RPKM of the
tight promoter-proximal region divided by the RPKM of the gene body region.
(D) Number of NET-seq reads at three zoom levels around the PRPF38B locus for HeLa S3 cells. Reads that aligned to the positive strand (+) are in violet, and
reads that aligned to the negative strand () are in red. The TSS and the direction of transcription are indicated by an arrow. Annotation of exonic and intronic
regions is shown as boxes and lines, respectively.
RPKM, reads per kb per million uniquely aligned reads at Pol-II-transcribed genes; TSS, transcription start site; pA, polyadenylation site. See also Figure S2.2011; Core et al., 2008; Neil et al., 2009; Seila et al., 2008; Xu
et al., 2009). We analyzed this phenomenon for a stringently
defined set of Pol-II-transcribed genes that do not overlap other
genes within 2.5 kb of the TSS and polyadenylation site and are
longer than 2 kb to avoid misinterpreting transcription from other
genes as antisense transcription (n = 3,937 genes). Analysis of
regions 2 kb upstream and downstream of transcription start
sites with broad coverage and no sign of missing overlapping
annotation (n = 1,488; see Experimental Procedure) reveals
divergent transcription in 77% of promoter-proximal regions,
consistent with other studies (Figure 3A, left) (Core et al., 2008;
Seila et al., 2008). Surprisingly, close inspection of our data re-
vealed an unappreciated form of antisense transcription near
promoters. At 25% of promoter-proximal regions, we observe
antisense transcription originating downstream of sense tran-
scription (Figure 3A, right), which we term convergent transcrip-
tion. Convergent transcription is clearly observed at single-pro-
moter regions (Figures 3B and 3C), and in most cases, such as
near the KLHL9 promoter, convergent transcription is accompa-
nied by divergent transcription (Figure 3B). However, it also
occurs in the absence of divergent transcription (for example,544 Cell 161, 541–554, April 23, 2015 ª2015 Elsevier Inc.FAM133B, Figure 3C). Furthermore, GRO-seq also detects
these transcripts. A re-analysis of mouse embryonic stem cell
data reveals convergent antisense transcription (Jonkers et al.,
2014) (Figure S3A).
To characterize the structural attributes on these modes of
transcriptional activity, distances between sense and antisense
peaks were determined for each promoter-proximal region (Fig-
ure 3D). A stereotypical distance (250 ± 50 bp) separates the
sense and antisense peaks in divergent transcription, while the
sense and antisense peaks in convergent transcription are also
separated by a stereotypical distance (150 bp ± 50 bp), indi-
cating that convergent antisense transcription is not simply the
result of spurious antisense transcription initiation events across
the promoter-proximal region (Figure 3D).
A Distinct Chromatin Structure Associated with
Convergent Transcription
Many chromatin modifiers control antisense transcription
(Churchman and Weissman, 2011; DeGennaro et al., 2013;
Kim et al., 2012; Marquardt et al., 2014; Whitehouse et al.,
2007), and we asked how promoter-proximal transcriptional
Figure 3. Convergent Transcription
Observed at the Promoter-Proximal Re-
gions of Lower-Expressed Genes
(A) Promoters are classified depending onwhether
they contain a peak of convergent antisense Pol II
transcription, as illustrated by the cartoon above
the heat maps. A stringent set of promoter-prox-
imal regions was selected for analysis to ensure
that transcription arising from other transcription
units would not bias classification (see Experi-
mental Procedures). Heatmaps of Pol II scaled
density are displayed for each class (left, no
convergent peak, n = 931 genes; right, convergent
peak, n = 373). For each gene, the sense (violet)
and antisense (red) raw signal is analyzed sepa-
rately and normalized to vary from 0 to 1. Both
signals are superposed, centered on the major
sense transcription peak. Genes are sorted by the
distance between the sense and antisense peaks.
Mean Pol II density profile is displayed below the
heatmaps, where raw sense and antisense data
are normalized together to vary between 0 and 1
and smoothed with a 50 bp sliding window
average. Solid lines indicate the mean values, and
shading shows the 95% confidence interval.
Sense transcription is shown in violet, and anti-
sense transcription is shown in red.
(B and C) Examples of NET-seq reads in two
promoter-proximal regions that display conver-
gent Pol II transcription.
(D) Histogram of distances between the major
peak of Pol II density in the sense direction and the
peak(s) in the antisense direction for all promoters
with convergent and/or divergent peaks (n =
1,304).
(E) Distributions of the percentage of genes with a
given Pol II density in the gene body region, as
defined in Figure 2A. Genes with only convergent
transcription (yellow, n = 151) or only divergent
transcription (blue, n = 931) in their promoter-
proximal regions are compared. The p value is
calculated by the Kolmogorov-Smirnov test.
RPKM, reads per kb per million uniquely aligned
reads at Pol-II-transcribed genes. See also
Figure S3.activity relates to local chromatin structure. We used DNase-seq
to map regions of open chromatin and highly positioned nucleo-
somes in the same HeLa S3 cells used for NET-seq (Thurman
et al., 2012). We examined the distribution of DNase I accessi-
bility relative to promoter-proximal peaks in NET-seq dataCell 161, 541–5(Figure 4). At genes that have a sense
Pol II peak (representing promoter-proxi-
mally paused Pol II), we observe strong
DNase I hypersensitivity upstream of the
peak, determining the canonical pro-
moter (Figure 4A), and reduced DNase
sensitivity downstream of the peak corre-
sponding to the +1 nucleosome. Thus,
promoter-proximal pausing occurs prior
to the +1 nucleosome in mammalian
cells. Comparison of DNase I data rela-tive to the divergent antisense peak shows that this transcrip-
tional activity originates from the 50 side of the promoter
hypersensitivity region, consistent with the model that divergent
antisense transcription is a consequence of an open chromatin
region (Seila et al., 2009) (Figure 4C). In contrast, genes with54, April 23, 2015 ª2015 Elsevier Inc. 545
Figure 4. Convergent Transcription Is Associated with a Distinct Chromatin Structure
(A–C) Heatmaps showing DNase I accessibility in HeLa S3 cells surrounding all (A) promoters (n = 1,304) aligned to the sense NET-seq peak, (B) promoters that
have convergent transcription (n = 373) aligned to the antisense convergent NET-seq peak, and (C) promoters that have divergent transcription (n = 1,153) aligned
to the antisense divergent peak. Below each heatmap is the mean DNase I accessibility profile of the region shown in the heatmap. The raw data are smoothed
with a 150 bp sliding window in 20 bp steps. Solid lines indicate the trimmed mean (removing 5% of extreme data points). Above each heatmap are
arrows showing the transcriptional activity observed in each promoter-proximal region. A cartoon displays the chromatin structure determined by analysis of the
DNase-seq data.convergent transcription show two distinct peaks in DNase I
hypersensitivity: a canonical promoter peak and a downstream
peak located proximal to the convergent antisense peak (Fig-
ure 4B). Thus, convergent antisense transcription likely origi-
nates locally. Furthermore, the dip between the two peaks of
DNase I hypersensitivity likely represents the +1 nucleosome,
consistent with the 150 bp spacing between the sense and
convergent antisense Pol II peaks (Figures 3D and 4B). These re-
sults indicate that convergent transcription reflects sense and
antisense transcription that initiates locally and undergoes pro-
moter-proximal pausing flanking the +1 nucleosome.
Convergent Transcription Is a Feature of Lower-
Expressed Genes
Convergent transcription can regulate gene expression through
transcriptional interference mechanisms (Callen et al., 2004; El-
ledge and Davis, 1989; Gullerova and Proudfoot, 2012; Hobson
et al., 2012; Martens et al., 2004; Prescott and Proudfoot, 2002;
Shearwin et al., 2005). Thus, we considered whether promoter-
proximal convergent transcription may be involved in release of
Pol II from promoter-proximal pausing into productive elonga-546 Cell 161, 541–554, April 23, 2015 ª2015 Elsevier Inc.tion. We compared Pol II density within the gene body (+1 kb
after the transcription start site to the polyadenylation site, illus-
trated in Figure 2A) at genes that display only convergent tran-
scription to genes that display only divergent transcription.
Notably, genes with only convergent transcription near their
promoters show consistently less transcription downstream of
their promoter regions (Figure 3E) (1.8-fold less on average,
Kolmogorov–Smirnov test, p < 106). Comparison of less strin-
gently defined sets of genes, such as all genes with convergent
transcription to all genes without convergent transcription,
showed a similar effect (Figure S3B). In agreement with this
observation, analysis of ENCODE HeLa S3 ChIP-seq data re-
veals that H3K79me2 histone marks, which correlate with tran-
scription elongation, occur at significantly lower levels in the
gene bodies of genes with convergent antisense transcription
(Figure S3C) (Consortium, 2012; Guenther et al., 2007; Wozniak
and Strahl, 2014). Thus, convergent antisense transcription
could interfere with productive transcription elongation or could
be a consequence of less-productive elongation. Either of these
possibilities could be directly mediated by Pol II or by another
factor, such as chromatin.
Figure 5. P-TEFb Inhibition Proportionally Affects Levels of Sense
Transcription and Convergent Antisense Transcription
(A) Western blot analysis of whole-cell extract of HeLa S3 cells with flavopiridol
(FP) treatment (1 hr). The percentage at the bottom of each lane is the amount
of the respective protein (as determined by image quantification) before and
after FP treatment. GAPDH serves as a loading control.
(B) Meta-gene analysis of NET-seq data from HeLa S3 cells treated with
1 mM FP (purple and red) or DMSO control (gray) for 1 hr. Arrows indi-
cate regions where transcription is affected by FP treatment. Genes that
had convergent and/or divergent peaks (described in Experimental
Procedures) in both data sets are included in the analysis (n = 615). NET-
seq signal from each promoter region (± 2.5 kb centered at the sense
transcription peak) are binned into 10 bp windows. For each sample,
sense and antisense signal are normalized together to vary betweenTo test whether convergent antisense transcription is a conse-
quence of reduced sense transcription elongation, we globally
suppressed productive elongation by inhibiting positive tran-
scription elongation factor b (P-TEFb). Most promoter-proxi-
mally paused Pol II are released through recruitment of P-TEFb
that phosphorylates multiple proteins, including Ser2 residues
of the Pol II CTD (Kim and Sharp, 2001; Peterlin and Price,
2006). Therefore, active P-TEFb greatly facilitates the transition
to productive elongation but does not affect transcription initia-
tion (Lis et al., 2000; Peterlin and Price, 2006; Rahl et al.,
2010). We performed NET-seq analysis on HeLa S3 cells
exposed to the P-TEFb inhibitor flavopiridol (FP) (Chao and
Price, 2001) or DMSO alone. As expected, after 60 min, FP
reduced Pol II CTD Ser2 phosphorylation, but phosphorylation
of Ser5 residues and overall Pol II levels remained unchanged
(Figures 5A and S4). We generated NET-seq libraries from
HeLa S3 cells after a 1 hr FP treatment or DMSO control (FP
treatment NET-seq data set, 486million total reads, 262 uniquely
mapped reads; DMSO control NET-seq data set, 491 million to-
tal reads, 263 million uniquely mapped). In agreement with pre-
vious studies, we observe a global decrease in Pol II density
outside of promoter-proximal regions compared to the DMSO
control (Figure 5B, arrows) (Flynn et al., 2011; Jonkers et al.,
2014; Rahl et al., 2010). Thus, FP treatment reduces productive
elongation of most genes. To quantify the effect of FP treatment
on convergent transcription, we calculated the ratio of con-
vergent antisense to sense transcription at all promoter-proximal
regions. If convergent transcription were a simple consequence
of lower expression, it should not only be increased propor-
tionally to promoter-proximal sense transcription following FP
treatment, but importantly, it should appear in genes where it
was not detected before. We observe that the convergent anti-
sense-to-sense transcription ratio remains constant following
FP treatment, indicating that sense and convergent antisense
transcription levels covary, and we do not detect a new subpop-
ulation of genes with convergent transcription in their promoter-
proximal regions (Figure 5C). This result suggests that the lack of
sense-productive transcription elongation is not sufficient to
induce convergent transcription. Thus, if convergent antisense
transcription is not a simple consequence of low sense expres-
sion, then it may contribute to the cause.
Impact of Transcription Factor Occupancy on Pol II
Elongation
DNA-bound transcription factors (TFs) have the potential to
obstruct elongating Pol II. To investigate the relationship be-
tween TF occupancy and Pol II progress, we expanded our0 and 1 and then smoothed with a 50 bp sliding window. Solid lines
indicate the mean normalized Pol II density, and shading shows the 95%
confidence interval.
(C) A scatterplot comparing the convergent-to-sense ratio after treatment with
DMSO (control) and after FP treatment for a stringent subset of non-over-
lapping genes with at least 10 reads across the 500 bp region after TSS in both
samples (n = 1,667). The ratio is the sum of NET-seq signal on the antisense
strand versus the sense strand across the 500 bp region after the TSS. The
handful of genes with a ratio of 0 are not plotted.
TSS, transcription start site. See also Figure S4.
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Figure 6. Pol II Pausing Associated with Transcription Factor Occupancy
(A) Average NET-seq signal around 16,339 CTCFmotifs with accessible chromatin. In red is NET-seq signal oriented to the strand of the motif (Pol II transcription
from left to right), and in green is NET-seq on the other strand (Pol II transcription from right to left). The CTCF binding motif is pictured above. The NET-seq data
were smoothed by a 10 bp sliding window average.
(B) Mean NET-seq (red) and DNase I cleavage (gray) signal (10 bp windowed averages) surrounding the top 5,000 CTCF motifs sorted by NET-seq signal.
(C) Average NET-seq signal (smoothed by a 10 bp sliding window average) around 731 YY1motifs with accessible chromatin. In red is NET-seq signal oriented to
the strand of themotif (Pol II transcription from left to right), and in green is NET-seq on the other strand (Pol II transcription from right to left). The YY1 bindingmotif
is pictured above.
(D) Mean per nucleotide NET-seq (red) and DNase I cleavage (gray) signal surrounding the top 200 YY1 motifs sorted by NET-seq signal. Both signals are
presented as 10 bp windowed averages. Schematic of nucleosome positioning relative to YY1 inferred from DNase I accessibility is above plot.DNase-seq data from HeLa S3 cells to genomic footprinting
depth (269 million uniquely mapped genomic reads), enabling
detailed mapping of the occupancy of TF recognition sites within
DNase I hypersensitivity sites (DHSs). As CTCF is implicated in
Pol II pausing in vitro and within the cell (Shukla et al., 2011),
we quantified NET-seq signal and DNase-seq signal around
CTCF recognition sites within DHSs on both strands. We
observed higher Pol II density just upstream of the CTCF sites,
suggesting that CTCF might represent a barrier to Pol II elonga-
tion genome wide (Figures 6A and 6B). Interestingly, the NET-
seq signal around these sites differs in magnitude for each
strand, indicating that CTCFmay pose strand-specific obstacles
(Figure 6A).
As transcriptional pausing has been seen upstream of
nucleosomes in yeast and Drosophila cells (Churchman and
Weissman, 2011; Mavrich et al., 2008; Weber et al., 2014), we
investigated Pol II density around YY1, a canonical promoter-548 Cell 161, 541–554, April 23, 2015 ª2015 Elsevier Inc.centric transcription factor (Xi et al., 2007) thought to position +1
nucleosomes (Vierstra et al., 2014). Thus, we speculated that
YY1 occupancy might impact Pol II elongation. Given that
poly-zinc finger TFs engage DNA asymmetrically, we also spec-
ulated that any impact on Pol II might also be strand specific. We
observed a peak in NET-seq signal precisely at YY1 sites in
DHSs, consistent with YY1-directed pausing (Figures 6C and
6D). Strikingly, this effect was highly directional and is predomi-
nant when Pol II engages YY1 from the upstream direction (Fig-
ure 6D). These results indicate that TFs might directly regulate
Pol II elongation in direction- or strand-specific ways.
Fine Structure of Pol II Pausing along Constitutive and
Alternative Exons
Alteration to transcription elongation rates affects splicing out-
comes, which has led to the proposal of the kineticmodel of tran-
scription and splicing coupling (Dujardin et al., 2014; Fong et al.,
Figure 7. Pol II Density across Exons Reveals a Stereotypical Pausing Pattern that Depends on Splicing Outcome
(A) Schematic of the classification of constitutive, alternative retained, and alternative skipped exons based on annotated isoforms and detected levels in
cytosolic RNA-seq data.
(B) A stringent set of exons was selected for analysis from genes containing NET-seq signal ofR1 RPKM (B, see Experimental Procedures). Heatmaps andmeta-
exon analysis of HeLa S3 Pol II density across each type of exon, as defined in (A) (left to right: constitutive exons, n = 1,334; alternative retained, n = 14,582; and
alternative skipped, n = 6,348). NET-seq signal from each exon (± 25 bp) is normalized to vary from 0 to 1 (white to black scale in the heatmaps). Solid lines on the
meta-exon plots indicate the mean values, and the gray shading represents the 95% confidence interval. The single-nucleotide positions where splicing in-
termediates align (30 ends of introns and exons) were entirely removed from analysis (see Experimental Procedures) and appear as a blank position in the figures.
(C-E) Raw NET-seq reads across the constitutive exon 2 within the DDX3X gene (C), alternative retained exon 2 within the SIK1 gene (D), and the alternative
skipped exon 10 within the CD55 gene (E).
(F) Distribution of the percent of exons or introns with a given Pol II density.
RPKM, reads per kb per million Pol II uniquely aligned reads. See also Figure S5.2014; Ip et al., 2011; de la Mata et al., 2003; Roberts et al., 1998).
However, the degree to which transcription rate is modulated
locally around exons is unclear. Higher Pol II density at human
exons versus introns was reported using Pol II ChIP-seq and
ChIP-chip (Brodsky et al., 2005; Schwartz et al., 2009), but inanother study, no significant difference was observed (Spies
et al., 2009). Furthermore, the precise pattern across individual
exons could not be resolved. In Drosophila cells, PRO-seq
observed high Pol II density across exons and detected a high
enrichment of Pol II density at the 50 ends (Kwak et al., 2013).Cell 161, 541–554, April 23, 2015 ª2015 Elsevier Inc. 549
We analyzed NET-seq data at constitutive exons and revealed
significantly higher coverage than at introns in both HeLa S3 (2.4
3 higher) and HEK293T cells (2.23 higher) (p < 1015, Kolmo-
gorov–Smirnov test), suggesting that transcription elongation is
slower at exons in human cells (Figures 7A, 7B, 7F and S5A).
Any contamination from processed mRNA would inflate these
differences; however, our quality controls (Figures 1B, 1C, and
S1A) suggest that this is a small effect, if at all. Strikingly, NET-
seq signal across exons is not uniform: sharp increases in Pol
II density occur in the few base pairs surrounding the 50 and 30
ends of constitutive exons, indicating strong Pol II pausing at
exon boundaries (Figure 7B). As splicing intermediates are
known NET-seq contaminants (Figure S1G), we removed the
single bp positions where they align from analysis. Furthermore,
a broader peak of RNA polymerase density is present 17 nt
before the 30 end of exons. The general features of this pattern
are observed at single exons, for example, exons 2 of the
DDX3X and SIK1 genes (Figures 7C and 7D). Finally, we observe
similar trends in the NET-seq data from HEK293T cells (Fig-
ure S5B). This analysis suggests that exon borders impose a
structured barrier to Pol II elongation.
Most human exons can be alternatively spliced, with retained
exons varying between cell types (Pan et al., 2008; Wang et al.,
2008). We expanded our analysis to alternatively spliced exons
and investigated whether transcriptional pausing varies at
exons with different splicing outcomes. We focused our anal-
ysis on genes with a NET-seq RPKM of >1 in the gene body
(Figure S5A) and defined skipped exons as those undetected
in the cytoplasmic RNA-seq data (Figure 7A). As for constitutive
exons, retained alternative exons have higher Pol II density
compared to the density across introns (Figure 7F). These
exons also have a similar pausing pattern as constitutive exons,
which is visible by meta-exon analysis and at the single exon
(Figures 7B and 7D). Interestingly, Pol II density is lower at
skipped exons than at alternative retained exons (Figure 7F).
Strikingly, the Pol II density pattern is similarly shaped across
skipped and retained exons, albeit significantly different in
amplitude (Figures 7B and 7E). The residual pausing pattern
at skipped exons could be due to the small number of retained
exons that are misannotated as skipped. Finally, the same
differences in the Pol II density patterns across retained and
skipped exons are observed in HEK293T cells (Figure S5B).
Together, these data show that Pol II recognizes exon struc-
tures with different processing fates, suggesting that alterna-
tive splicing is kinetically coupled to transcription elongation
genome wide.
DISCUSSION
Here, we demonstrate that human NET-seq provides complete,
strand-specific maps of transcription at single-nucleotide reso-
lution. NET-seq thereby defines transcriptional pausing sites
and directly measures unstable transcripts. Finally, NET-seq
instantaneously reports the transcription status of genes, in
contrast to RNA-seq, which reports the balance between RNA
synthesis and degradation.
Our work describes an unappreciated aspect of promoter-
proximal transcription: the presence of convergent transcription550 Cell 161, 541–554, April 23, 2015 ª2015 Elsevier Inc.at many human genes. Importantly, we show that convergent
transcription is characteristic of lower-expressed genes, sug-
gesting a potential role in the regulation of promoter-proximal
pausing. Prominent DNase I hypersensitivity sites flanking the
convergent antisense peak indicate that promoter-proximal
convergent transcription reflects initiation at a defined promoter
located a characteristic distance from the canonical sense
promoter.
Other than expression level, only one commonality is found
between the genes with convergent transcription: the dinucleo-
tide CC occurs slightly more frequently in regions displaying
convergent transcription (12.4% ± 0.4% for convergent, 11.1%
± 0.2% for not convergent). Thus, it appears that convergent
transcription is a prevalent phenomenon that is not restricted
to a specific class of genes. An intriguing possibility is that
paused antisense Pol II directly blocks or clashes with sense
transcription, as can occur in yeast (Prescott and Proudfoot,
2002). The sense and convergent antisense peaks are too far
apart (150 bp) to reflect direct contact of paused polymerases,
but the DNase-seq data reveal that this distance likely repre-
sents the +1 nucleosome that is positioned between them. Inter-
ference could arise through positioning of the +1 nucleosome or
indirect mechanisms such as transcription-induced changes in
DNA topology, chromatin modifications, or transcription factor
occupancy. In any event, NET-seq data do not resolve whether
sense and antisense transcription occur simultaneously, as the
approach requires averaging over a population of cells. There-
fore, potential roles of convergent transcription during initiation,
elongation, and termination will have to be investigated within
cell populations and at the single-cell level.
Our study yields a global picture of how transcription elonga-
tion is altered at alternatively spliced exons in human cells.
Changes in transcription elongation influence alternative
splicing, which is thought to bemediated either by the differential
recruitment of splicing factors (recruitment model) or by biasing
kinetic competition between multiple splicing outcomes (kinetic
model) (Bentley, 2014; Dujardin et al., 2013; Kornblihtt et al.,
2004). Here, we show that alternative splicing outcomes in hu-
man cells are associated with Pol II exon density and strong
pauses at the 50 and 30 ends, consistent with the kinetic model.
What causes pauses at exons is an important question. Nucleo-
somes can influence transcriptional pausing (Churchman and
Weissman, 2011; Hodges et al., 2009; Izban and Luse, 1991;
Skene et al., 2014), and, importantly, nucleosome occupancy
and histone modifications transition at exon boundaries accord-
ing to splice site strength (Andersson et al., 2009; Chodavarapu
et al., 2010; Huff et al., 2010; Schwartz et al., 2009; Spies et al.,
2009; Tilgner et al., 2009). DNA sequence and DNA methylation
at exon boundaries could contribute to pausing because
sequence elements have been shown to cause transcriptional
pausing (Gelfman et al., 2013; Herbert et al., 2006; Kassavetis
and Chamberlin, 1981; Larson et al., 2014; Maizels, 1973; Vve-
denskaya et al., 2014). Additionally, transcription factors could
underlie pausing at retained exons, as is the case with CTCF
binding at exon 5 of the CD45 gene (Shukla et al., 2011). The
broad peak of Pol II density 17 bp from the 30 end of the exon
may reflect Pol II backtracking during the recovery from the
strong pause at the 30 end of the exon. Backtracking would
produce small cleavage products, consistent with the population
of tiny RNAs that were previously identified in this region (Taft
et al., 2009).
We expect adaptation of human NET-seq to any human cell
type to be straightforward, resulting in a tool to illuminate a
variety of biological processes. Future applications include
high-resolution analyses of transcription regulation across
cell types, responses to signaling pathways, and cellular
differentiation.
EXPERIMENTAL PROCEDURES
Cell Fractionation and RNA Purification
Cell fractionation is performed as described by (Bhatt et al., 2012; Pandya-
Jones and Black, 2009) and based on (Wuarin and Schibler, 1994) with mod-
ifications. All steps are conducted on ice or at 4C and in the presence of
25 mM a-amanitin, 50 units/ml SUPERaseIN and Protease inhibitors cOm-
plete. HeLa S3 cells and HEK293T cells are grown in DMEM containing
10% FBS, 100 U/ml penicillin, and 100 mg/ml streptomycin to a confluency
of 90%. Following lysis of 1 3 107 cells, the nuclei are washed with the nuclei
wash buffer (0.1% Triton X-100, 1 mM EDTA, in 13 PBS) to remove cyto-
plasmic remnants. Nuclei lysis is performed without MgCl2 (1% NP-40,
20 mM HEPES [pH 7.5], 300 mM NaCl, 1 M Urea, 0.2 mM EDTA, 1 mM
DTT). The success of cell fractionation is monitored by western blot analysis
and subcellular RNA-seq.
Sequencing Library Constructions
For NET-seq, the library preparation is performed as described by Churchman
and Weissman (2011, 2012) with modifications. For 30 RNA ligation, a pre-ad-
enylated DNA linker with a mixed random hexameric barcode sequence at its
50 end is used. cDNA containing the 30 end sequences of a subset of mature
and heavily sequenced snRNAs, snoRNAs, rRNAs, and mitochondrial tRNAs
are specifically depleted using biotinylated DNA oligos (Table S1), as
described by Ingolia et al. (2012). For subcellular RNA-seq, the sequencing li-
braries are prepared as described in Churchman and Weissman (2012), with
the ribosomal RNA removed using the Ribo-Zero Magnetic Kit (Epicentre).
DNA libraries are sequenced by the NextSeq 500 and HiSeq 2000 Illumina
platforms.
Processing and Alignment of Sequencing Reads
Reads are trimmed and aligned using STAR (v2.4.0) (Dobin et al., 2013).
For NET-seq data, only the position matching the 50 end of the sequencing
read (after removal of the barcode), corresponding to the 30 end of the
nascent RNA fragment, is recorded with a Python script using HTSeq
package (Anders et al., 2015). Reverse transcription mispriming events
are identified and removed when molecular barcode sequences match
exactly to the genomic sequence adjacent to the aligned read. Reads
that align to the same genomic position and contain identical barcodes
are considered PCR duplication events and are removed. Splicing inter-
mediates have 30 hydroxyls and will enter NET-seq libraries and contribute
to the reads aligning to the exact single-nucleotide 30 ends of introns and
30 ends of exons (Figure S1G). Therefore, reads that map precisely at
the exact single-nucleotide ends of introns and exons are discarded,
and the single 1 bp genomic positions are not considered in subsequent
analysis.
Annotation of Exons and Introns
Clear exonic regions are identified by determining the minimum overlapping
exonic region of all isoforms that have an exon at that position. If the region
is present in all isoforms, it is considered a constitutive exon; otherwise, it is
labeled alternative. Alternative skipped exons are classified by those alterna-
tive exons that are entirely undetected in the cytoplasm RNA-seq data, and
the rest of the alternative exons are classified as retained. Constitutive intronic
regions are identified as the minimum intronic overlapping regions present in
all isoforms.NET-Seq Exon Metagene and Heatmap Analysis
The set of exons included in the analysis are required to be within genes of
an RPKM >1 in gene bodies (defined in Figure 2A) and not overlapping any
other annotated exon. They are required to begin and end at the same po-
sition in all isoforms that contain the exon. First and last exons of genes
are removed from analysis. NET-seq signal across each exon ±25 bp is
normalized to range between 0 and 1 so that each exon contributes to
the analysis with the same weight. Precise single-nucleotide genomic
loci where splicing intermediates map (exact 30 ends of introns and exons)
are not included in the analysis, and those locations are left blank in any
plots.
Analysis of Promoter-Proximal Regions
Promoter-proximal regions were carefully selected for analysis to ensure
that there is minimal contamination from transcription arising from other
transcription units. Starting with genes that are Pol II protein coding, non-
overlapping within a region of 2.5 kb upstream of the TSS and 2.5 kb
downstream of the polyA site, and longer than 2 kb, NET-seq data at pro-
moter-proximal regions are required to have a coefficient of variation >0.5
and have at least 40 positions covered in the sense strand. Within a 4 kb
window surrounding the TSS, peaks were identified in the sense from these
genes. If >40 bases on the antisense strand have NET-seq signal, peaks
were also identified on the antisense strand. Promoter regions with an anti-
sense peak located downstream of the sense major peak are classified as
displaying convergent transcription. Promoter regions with an antisense
peak located upstream of the sense major peak are classified as displaying
divergent transcription.
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